News
May 13, 2025—enVVeno Medical Corporation announced the publication of 3-year outcomes from the first-in-human (FIH) study of the company’s ...
Promising results from the first-in-human study demonstrated that, at three-years post implantation, VenoValve remained safe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback